❭ Research by medical division ❭ Laboratory Medicine ❭ Dept. of Medical Biochemistry ❭ The Tumour Marker Group [Bolstad] ❭

Group members

Trine Bjøro, MD, professor. Group leader.

David Warren, PhD

Nils Bolstad, MD

Sigurd Bøe, PhD

Ragnhild Nome, MD

Johanna Géhin, MD

Rolf Anton Klaasen, MPharm

Åge Winje Brustad, Technician

Ann Magritt Liberg, Technician

 
Scroll to top

Home Dept. of Medical Biochemistry The Tumour Marker Group [Bolstad]

  • Group members
  • Research projects
  • Publications
  • Funding and collaborations

Recent publications

Grimstad T, Carlsen A, Kvaløy JT, Bolstad N, Warren DJ, Aabakken L, Lundin KEA, Karlsen L, Steinsbø Ø, Omdal R (2025)
Fatigue in Inflammatory Bowel Disease: No Effect of Serum Concentrations of Infliximab, Adalimumab or Anti-Drug Antibodies During Maintenance Therapy
Scand J Immunol, 101 (5), e70029
DOI 10.1111/sji.70029, PubMed 40289444

Rydland A, Heinicke F, Nyman TA, Trøseid AS, Flåm ST, Stensland M, Gehin J, Eikeland J, Øvstebø R, Mjaavatten MD, Lie BA (2025)
Newly-diagnosed rheumatoid arthritis patients have elevated levels of plasma extracellular vesicles with protein cargo altered towards inflammatory processes
Sci Rep, 15 (1), 11632
DOI 10.1038/s41598-025-96325-8, PubMed 40185859

Cavalcanti LM, Thomas WM, Warren DJ, Mathews VJ (2025)
Adaptive Feedforward Model Predictive Control for Torque Generation Through Asynchronous Intrafascicular Multi-Electrode Stimulation
IEEE Trans Biomed Eng, PP (in press)
DOI 10.1109/TBME.2025.3530924, PubMed 40031221

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)